ArticleThrombosis journal2025
Elevated tricuspid peak systolic gradient with enlarged right ventricle present during acute episode of pulmonary embolism predict subsequent chronic thromboembolic pulmonary hypertension.
Article in Thrombosis journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic thromboembolic pulmonary hypertension (CTEPH) is a progressive disease with poor outcome if left untreated. Identifying patients at risk of CTEPH already at acute pulmonary embolism (APE) would lead to earlier goal-directed management. Since echocardiography is frequently performed during APE we aimed to assess its predictive value for subsequent CTEPH.
methodsDuring follow up all symptomatic patients underwent diagnostic workup for CTEPH. Echocardiographic parameters recorded during the APE episode were analyzed for subsequent CTEPH.
resultsThe study included 625 patients (345 F, age 60.36 ± 17.71), 25 subjects (4%) (12 F; age 62.9 ± 18.8), were diagnosed with CTEPH. Patients with CTEPH presented at APE diagnosis more severe echocardiographic signs of right ventricular (RV) pressure overload. Multivariate analysis revealed that only tricuspid regurgitation peak gradient (TRPG), (OR = 1.05 CI95[1.03; 1.08], p < 0.001) and RV to left ventricle ratio (RV/LV), (OR = 9.86 CI95[2.26; 43.56], p = 0.002) were significant predictors of CTEPH. ROC analysis of TRPG for the diagnosis of CTEPH had AUC = 0.792 CI95[0.683-0.900], while RV/LV 0.777 CI95[0.675–0.878]. Combination of RV/LV ≥ 1.14 and TRPG ≥ 44mmHg (tricuspid regurgitation velocity (TRV) ≥ 3.3 m/s) present in 8.1% of patients identified high risk category of subsequent CTEPH with CTEPH incidence of 28.2% CI95[15.0-44.9%] (sensitivity 47.8% CI95[26.8–69.4%], specificity 93.9% CI95[91.3–95.9%], NPV 97.3% CI95[96.0-98.1%], PPV 28.2% CI95[18.4–40.7%]). TRPG < 44mmHg (TRV < 3.3 m/s) with RV/LV ratio < 1.14 present 66.7% of studied patents formed low risk group with CTEPH incidence of 1.6% CI95 [0.5–3.6%] (sensitivity 21.7% CI95 [7.5–43.7%], specificity 31.1% CI95 [26.9–35.5%].
conclusionsCombination of TRPG ≥ 44mmHg (TRV ≥ 3.3 m/s) with RV/LV ≥ 1.14 present at echocardiography during acute PE identifies patients at high risk of subsequent CTEPH and our opinion warrants their active screening for CTEPH.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.